Hair Loss Treatment Research in 2026: Where Things Stand

Minoxidil and finasteride remain the two most established, evidence-backed medical treatments for pattern hair loss, and research through 2026 has continued to refine how they are best used, including growing evidence for combination therapy and progress on newer investigational options.

Pattern hair loss is one of the concerns we see most often at our Hulhumalé clinic, so a clearer evidence picture is genuinely useful for patients here.

Combination therapy is emerging as the preferred approach

Rather than choosing one treatment over the other, real-world research has shown that combining minoxidil and finasteride produces stronger, more stable outcomes over time than either used alone for many patients. This has shifted how combination approaches are being considered as part of a first-line treatment plan for appropriate candidates, rather than adding a second treatment only once the first has been tried and found insufficient.

New investigational treatments in development

Several newer options are progressing through clinical trials, including extended-release oral minoxidil formulations designed specifically for pattern hair loss, and topical treatments targeting the androgen receptor pathway more directly. Early trial results for some of these newer approaches have been promising, though it is worth being clear that investigational treatments are not the same as approved, widely available options, and it will take time before any of them are established as standard care.

Safety context worth knowing

Finasteride side effects, including sexual side effects and mood changes, occur in a small minority of patients and are typically reversible on stopping the medication. This is useful context for patients who have heard concerning stories online but have not seen the actual incidence rates discussed by a clinician.

Where regenerative treatment fits alongside medical therapy

For patients already using minoxidil, finasteride or both, regenerative treatment such as exosome therapy is often used as a complementary addition rather than a replacement, supporting follicle activity while medical therapy addresses the underlying hormonal driver. See our comparison of PRP and exosome therapy for more detail on how these regenerative options work.

Our approach at the clinic

We discuss medical options honestly at consultation, including when they may not be appropriate (such as during pregnancy), and we build treatment plans around what the current evidence actually supports rather than what is newest or most heavily marketed.

Frequently asked questions

Is PRP or exosome therapy better supported by current research?

Both have growing evidence for hair thinning, with PRP having a longer track record and exosomes being newer; the right choice depends on your specific pattern of hair loss.

Can hair loss treatments be used during pregnancy?

Some regenerative hair treatments are not recommended during pregnancy, which is discussed openly at consultation before any plan is agreed.

How long before research-backed hair loss treatments show results?

Most patients need a course of several sessions spaced weeks apart before visible improvement in shedding or density appears.